반응식
[O:1]1[C:6]2[CH:7]=[CH:8][CH:9]=[C:10]([CH:11]([NH2:13])[CH3:12])[C:5]=2[O:4][CH2:3][CH2:2]1.[CH3:14][NH:15][C:16]([C:18]1[CH:23]=[C:22]([O:24][C:25]2[CH:36]=[CH:35][C:28]3[N:29]=[C:30](S(C)=O)[O:31][C:27]=3[CH:26]=2)[CH:21]=[CH:20][N:19]=1)=[O:17]>C1COCC1>[CH3:14][NH:15][C:16]([C:18]1[CH:23]=[C:22]([O:24][C:25]2[CH:36]=[CH:35][C:28]3[N:29]=[C:30]([NH:13][CH:11]([C:10]4[C:5]5[O:4][CH2:3][CH2:2][O:1][C:6]=5[CH:7]=[CH:8][CH:9]=4)[CH3:12])[O:31][C:27]=3[CH:26]=2)[CH:21]=[CH:20][N:19]=1)=[O:17]참가 물질
4
반응물 2
생성물 1
시약·촉매·용매 1
실험 절차
To a solution of 1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-ethylamine (3 eq) in THF was added 4-(2-methanesulfinyl-benzooxazol-6-yloxy)-pyridine-2-carboxylic acid methylamide (1 eq). This was stirred at room temperature for 8 hours, concentrated and the residue was purified by preparatory reverse phase HPLC. MH+=447.1.
후처리
- concentrationconcentrated
- customthe residue was purified by preparatory reverse phase HPLC
출처 및 근거
- ORD 기록
- ord-e97f334a6cfa450b8285ab30fdd4d2f4
- 출처 데이터셋
- uspto-grants-2014_04
- 특허 번호
- US08710048B2
연결된 노트
불러오는 중…